Publications & Works

Publication Network
Articles 8
All (8)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (7)
ESCI (1)
Scopus (7)
TRDizin (4)

1. Successful treatment with rituximab of a type 2 diabetes patient with antibody-mediated insulin resistance syndrome: A case report

Cakmak R., Tekin S., HACİŞAHİNOĞULLARI H., MUTLU Ü., Caklili O. T., Nasibopva V. S., et al.
MEDICINE , vol.104, no.29, 2025 (SCI-Expanded) identifier identifier identifier

2. Clinical Characteristics and Development of Complications Differ Between Adult-Onset and Child–Adolescent-Onset Type 1 Diabetes: A Report From a Tertiary Medical Center in Türkiye

Çakmak R., Çaklılı Ö. T., Ok A. M., Mutlu Ü., Sarıbeyliler G., Nasifova V. S., et al.
Journal of Diabetes Research , vol.2025, no.1, 2025 (SCI-Expanded) identifier identifier

3. RE: Is There a More Practical Way for Screening Minimal Hepatic Encephalopathy?

EYİCE KARABACAK D., Ok A. M., SONSUZ A., Senocak M. S., Durak M. N., oezdemir S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.34, no.6, pp.673-0, 2023 (SCI-Expanded) identifier identifier identifier identifier

4. The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic

Eyice D., Ok A. M., SONSUZ A., Senocak M. S., Durak M. N., ÖZDEMİR S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.34, no.5, pp.560-567, 2023 (SCI-Expanded) identifier identifier identifier identifier

5. Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma

Caklili O. T., Ok A. M., Istemihan Z., Selcukbiricik Ö., Yarman S.
ANNALES D ENDOCRINOLOGIE , vol.83, no.1, pp.9-15, 2022 (SCI-Expanded) identifier identifier identifier

6. OUR EXPERIENCE OF ENDOSCOPIC TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: OUTCOMES AND COMPLICATION RATES IN 48 PATIENTS

Unal T. C., Ozturk M., Dolas I., Ozata M. S., Dolen D., Mutlu U., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.85, pp.472-476, 2022 (ESCI) Creative Commons License identifier identifier

7. COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?

ÇAKMAK R., TELCİ ÇAKLILI Ö., ÇELİK A. M., MUTLU Ü., Nasıfova V., SARIBEYLİLER G., et al.
Turkish Journal of Diabetes and Obesity , vol.5, no.3, pp.279-284, 2021 (Peer-Reviewed Journal) Sustainable Development identifier

8. Cardiovascular Risk Factors and Comorbid Diseases in Takayasu's Arteritis

Masyan H., Esatoglu S. N., Celik A. M., Hamuryudan V., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY , vol.69, 2017 (SCI-Expanded) identifier
Papers Presented at Peer-Reviewed Scientific Conferences 18

1. Factors Affecting Quality of Life in Patients with Acromegaly: Single Center Experience

Ok A. M., Bektaş F., Bilik Oyman G., Mutlu Ü., Hacişahinoğulları H., Yenidünya Yalın G., et al.
25 th European Congress of Endocrinology - ECE 2023, İstanbul, Turkey, 13 - 16 May 2023, pp.1-3, (Summary Text) Creative Commons License

2.

Telci Çaklılı Ö., Ok A. M., Mutlu Ü., Hacişahinoğulları H., Yenidünya Yalın G., Gül N., et al.
43. TÜRKİYE ENDOKRİNOLOJİ VE METABOLİZMA HASTALIKLARI KONGRESİ 2022, Antalya, Turkey, 18 - 22 May 2022, pp.197, (Summary Text) Creative Commons License

3. Tiroid orbitopatisinde klinik aktivite skoru ile inflamatuar biyobelirteçlerin ilişkisi

ACARBAY A., ÇELİK A. M., MUTLU Ü., YENİDÜNYA YALIN G., GÜL N., SOYLUK SELÇUKBİRİCİK Ö., et al.
43. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Turkey, 18 - 22 May 2022, pp.179-180, (Summary Text) Creative Commons License

4. Covi̇d-19 İnfeksi̇yonu Sonrasi Prezente Olan Ağir Ti̇roi̇d Orbi̇topati̇si̇

Mutlu Ü., Ok A. M., Hacişahinoğulları H., Öztürker C., Gül N., Soyluk Selçukbiricik Ö., et al.
9. Türkiye Tiroid Hastalıkları E-Kongresi, İstanbul, Turkey, 1 - 04 December 2021, pp.45, (Summary Text) Creative Commons License

5.

Doğan E. E., Rasulova N., Telci Çaklılı Ö., Nasıfova V., Sarıbeyliler G., Mutlu Ü., et al.
18. Metabolik Sendrom Kongresi 2021, Muğla, Turkey, 16 - 19 September 2021, pp.111, (Summary Text) Creative Commons License

6.

Mutlu Ü., Ok A. M., Telci Çaklılı Ö., Hacişahinoğulları H., Yenidünya Yalın G., Gül N., et al.
57. Ulusal Diyabet Metabolizma ve Beslenme Hastalıkları Kongresi, Muğla, Turkey, 01 June 2021 - 05 June 2022, pp.305-306, (Summary Text) Creative Commons License

7.

Çakmak R., Telci Çaklılı Ö., Ok A. M., Mutlu Ü., Sarıbeyliler G., Nasifova V., et al.
57. Ulusal Diyabet Metabolizma ve Beslenme Hastalıkları Kongresi, Muğla, Turkey, 1 - 05 June 2021, pp.239, (Summary Text) Creative Commons License Sustainable Development

8. What should be the optimal testosterone level to improve the symptoms of hypogonadism in male macroprolactinomas?.

Telci Çaklılı Ö., Ok A. M., İstemihan Z., Soyluk Selçukbiricik Ö., Yarman E. S.
23 th European Congress of Endocrinology (ECE) 2021, 22 - 26 May 2021, pp.1-3, (Summary Text) Creative Commons License

9.

Nasıfova V., Çakmak R., Ok A. M., Mutlu Ü., Sarıbeyliler G., Telci Çaklılı Ö., et al.
42. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, İstanbul, Turkey, 19 - 23 May 2021, pp.322, (Summary Text) Creative Commons License

10.

Sarıbeyliler G., Mutlu Ü., Muslu B., Erel Gezegen C., Ok A. M., Çakmak R., et al.
56. Ulusal Diyabet Metabolizma ve Beslenme Hastalıkları , İstanbul, Turkey, 3 - 10 November 2020, pp.122-123, (Summary Text) Creative Commons License

11.

Sarıbeyliler G., Kapar C., Yılmaz A., İdiz C., Mutlu Ü., Nasıfova V., et al.
56. Ulusal Diyabet Metabolizma ve Beslenme Hastalıkları Kongresi, İstanbul, Turkey, 3 - 10 November 2020, pp.120-121, (Summary Text) Creative Commons License

12. Acidosis is not a sine qua non for DKA

SARIBEYLİLER G., Kapar C., YILMAZ A., Alibeyoğlu A., İDİZ C., MUTLU Ü., et al.
22nd European Congress of Endocrinology, 23 May 2020, (Full Text)

13.

Çakmak R., Oghyanous G. A., Telci Çaklılı Ö., Ok A. M., Mutlu Ü., Sarıbeyliler G., et al.
Geleneksel İç Hastalıkları Günleri – İnteraktif Güncelleştirme 2020, Sakarya, Turkey, 12 - 15 March 2020, pp.43-44, (Summary Text) Creative Commons License

14. An Extreme Cause of Vision Loss and Neuropathy in a Diabetic Patient

Ok A. M., Mutlu Ü., Bahar M., Lahin E., Anıl K. U., Yenidünya Yalın G., et al.
EndoBridge 2019, Antalya, Turkey, 24 - 27 October 2019, pp.76, (Summary Text) Creative Commons License Sustainable Development

15. LONG-TERM OUTCOMES OFKIDNEY TRANSPLANTATIONIN GENETIC DISEASES

Guller N. G., Demir E., Ucar A. R., Celik A. M., Yazici H., Caliskan Y., et al.
55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), Copenhagen, Denmark, 24 - 27 May 2018, vol.33, (Summary Text) identifier

16. EFFICACY OF INTRAVENOUS CYCLOSPORINE IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS RECURRENCE AFTER RENAL TRANSPLANTATION

Celik A. M., Demir E., Yalcin F., Yelken B., Ucar A. R., Turkmen A.
55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), Copenhagen, Denmark, 24 - 27 May 2018, vol.33, (Summary Text) identifier

17. ASSOCIATED INFLAMMATORY DISEASES IN TAKAYASU'S ARTERITIS: THE MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Ugurlu S., Hatemi G., Hamuryudan V., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 25 - 28 March 2017, vol.56, pp.47, (Summary Text) identifier

18. Postprandial, but not fasting insulin secretion is augmented in migraine. are migraineurs at high risk for future insulin resistance syndrome?

OŞAR SİVA Z., BALCI H., KONUKOĞLU D., ÇELİK A. M., SAİP S., SİVA A., et al.
2nd European Headache and Migraine Trust International Congress-EHMTIC., Nice, France, 28 - 31 October 2010, pp.0-528, (Full Text)
Metrics

Publication

26

Publication (WoS)

10

Publication (Scopus)

7

Citation (WoS)

1

H-Index (WoS)

1

Citation (Scopus)

2

H-Index (Scopus)

1

Citation (TrDizin)

1

H-Index (TrDizin)

1

Citation (Sum Other)

1

Project

1

Open Access

12
UN Sustainable Development Goals